End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.07 CNY | +2.94% | +3.79% | -11.46% |
Dec. 05 | Tasly Pharmaceutical Subsidiary Gets Drug Registration for Muscle Spasms Drug | MT |
Oct. 28 | Tasly Pharmaceutical's Q3 Profit Falls 45%; Shares Slide 3% | MT |
Chart calendar Tasly Pharmaceutical Group Co., Ltd
Upcoming events on Tasly Pharmaceutical Group Co., Ltd
Past events on Tasly Pharmaceutical Group Co., Ltd
2024-10-25 | Q3 2024 Earnings Release |
2024-08-23 | Q2 2024 Earnings Release |
2024-05-08 02:30 am | Annual General Meeting |
2024-04-25 | Q1 2024 Earnings Release |
2024-04-15 | Q4 2023 Earnings Release |
2024-01-03 02:30 am | Extraordinary Shareholders Meeting |
2023-10-27 | Q3 2023 Earnings Release |
2023-08-25 | Q2 2023 Earnings Release |
2023-04-26 03:00 am | Annual General Meeting |
2023-04-24 | Q1 2023 Earnings Release |
2023-03-27 | Q4 2022 Earnings Release |
2022-10-25 | Q3 2022 Earnings Release |
2022-09-05 03:30 am | Extraordinary Shareholders Meeting |
2022-08-19 | Interim 2022 Earnings Release |
2022-04-25 | Q1 2022 Earnings Release |
2022-04-20 02:30 am | Annual General Meeting |
2022-03-21 | FY 2021 Earnings Release |
2022-01-11 01:30 am | Extraordinary Shareholders Meeting |
2021-10-26 | Q3 2021 Earnings Release |
2021-08-25 | Interim 2021 Earnings Release |
Past dividends on Tasly Pharmaceutical Group Co., Ltd
2024-12-05 | Interim Payment 0.07 CNY |
2024-10-09 | Interim Payment 0.26 CNY |
2024-05-28 | Annual 0.33 CNY |
2023-05-21 | Annual 0.33 CNY |
2022-06-19 | Annual 0.33 CNY |
2021-06-23 | Annual 0.33 CNY |
2020-06-11 | Annual 0.33 CNY |
2019-06-12 | Annual 0.3 CNY |
2018-06-04 | Annual 0.4 CNY |
2017-06-14 | Annual 0.56 CNY |
2016-05-24 | Annual 0.42 CNY |
2015-05-20 | Annual 0.39 CNY |
2014-06-18 | Annual 0.35 CNY |
2013-05-21 | Annual 0.2 CNY |
2012-06-06 | Annual 0.7 CNY |
2011-05-23 | Annual 0.6 CNY |
2010-06-06 | Annual 0.4 CNY |
2009-04-12 | Annual 0.4 CNY |
2008-04-29 | Annual 0.3 CNY |
2007-05-29 | Annual 2.803 CNY |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 7 952 7 560 5.19% | 8 593 8 413 2.14% | 8 674 9 188 -5.59% | 8 911 | 9 424 | 10 074 |
EBITDA Million CNY | Released Forecast Spread | 3 153 2 175 45% | 295 1 313 -77.56% | 1 663 2 131 -21.94% | 1 946 | 2 159 | 2 329 |
EBIT Million CNY | Released Forecast Spread | 2 733 1 638 66.86% | -153 1 154 -113.26% | 1 228 1 525 -19.49% | 1 263 | 1 499 | 1 679 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 2 724 1 638 66.31% | -160 -75,4 -112.84% | 1 221 1 463 -16.51% | 1 256 | 1 533 | 1 752 |
Net income Million CNY | Released Forecast Spread | 2 359 1 463 61.29% | -257 -178 -43.79% | 1 071 1 216 -11.9% | 1 021 | 1 305 | 1 489 |
EPS CNY | Released Forecast Spread | 1,57 0,97 62.28% | -0,17 -0,12 -41.67% | 0,72 0,81 -10.69% | 0,69 | 0,87 | 1,00 |
Announcement Date | 30/03/22 | 27/03/23 | 15/04/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 2 103 2 709 -22.38% | 2 049 2 208 -7.22% | 2 323 2 541 -8.58% | |||||||||
EPS CNY | Released Forecast Spread | 0,18 0,23 -22.87% | 0,29 0,28 3.57% | 0,22 0,23 -4.35% | 0,03 0,16 -81.25% | 0,20 | 0,24 0,21 14.29% | 0,12 0,21 -42.86% | 0,16 | 0,22 | 0,38 | 0,24 | 0,23 |
Announcement Date | 24/04/23 | 25/08/23 | 27/10/23 | 15/04/24 | 25/04/24 | 23/08/24 | 25/10/24 | - | - | - | - | - |
Past sector events for Tasly Pharmaceutical Group Co., Ltd
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600535 Stock
- Calendar Tasly Pharmaceutical Group Co., Ltd